Feasibility of High-dose Iodine-131-metaiodobenzylguanidine Therapy for High-risk Neuroblastoma Preceding Myeloablative Chemotherapy and Hematopoietic Stem Cell Transplantation: a Study Protocol

OBJECTIVE(S): High-risk neuroblastoma is a childhood cancer with poor prognosis despite modern multimodality therapy. Internal radiotherapy using (131)I-metaiodobenzylguanidine (MIBG) is effective for treating the disease even if it is resistant to chemotherapy. The aim of this study is to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Araki, Raita, Nishimura, Ryosei, Inaki, Anri, Wakabayashi, Hiroshi, Imai, Yasuhito, Kuribayashi, Yoshikazu, Yoshimura, Kenichi, Murayama, Toshinori, Kinuya, Seigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038972/
https://www.ncbi.nlm.nih.gov/pubmed/29998150
http://dx.doi.org/10.22038/aojnmb.2018.29845.1203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038972/
https://www.ncbi.nlm.nih.gov/pubmed/29998150
http://dx.doi.org/10.22038/aojnmb.2018.29845.1203

Ejemplares similares